Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 24 |
NetGPI | no | yes: 0, no: 24 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A0A3S7WYG1
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0016567 | protein ubiquitination | 7 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0032446 | protein modification by small protein conjugation | 6 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 24 |
GO:0005509 | calcium ion binding | 5 | 18 |
GO:0043167 | ion binding | 2 | 24 |
GO:0043169 | cation binding | 3 | 24 |
GO:0046872 | metal ion binding | 4 | 24 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 2 |
GO:0061630 | ubiquitin protein ligase activity | 5 | 2 |
GO:0061659 | ubiquitin-like protein ligase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 279 | 283 | PF00656 | 0.451 |
CLV_C14_Caspase3-7 | 299 | 303 | PF00656 | 0.343 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.591 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.326 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.326 |
CLV_PCSK_PC7_1 | 72 | 78 | PF00082 | 0.322 |
CLV_PCSK_SKI1_1 | 226 | 230 | PF00082 | 0.442 |
DEG_SPOP_SBC_1 | 102 | 106 | PF00917 | 0.713 |
DEG_SPOP_SBC_1 | 116 | 120 | PF00917 | 0.724 |
DOC_CYCLIN_RxL_1 | 211 | 221 | PF00134 | 0.329 |
DOC_MAPK_gen_1 | 226 | 234 | PF00069 | 0.481 |
DOC_MAPK_MEF2A_6 | 62 | 71 | PF00069 | 0.494 |
DOC_PP1_RVXF_1 | 212 | 219 | PF00149 | 0.342 |
DOC_PP4_MxPP_1 | 110 | 113 | PF00568 | 0.570 |
DOC_USP7_MATH_1 | 116 | 120 | PF00917 | 0.713 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.684 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.430 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.680 |
DOC_WW_Pin1_4 | 103 | 108 | PF00397 | 0.772 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.447 |
LIG_14-3-3_CanoR_1 | 174 | 179 | PF00244 | 0.578 |
LIG_APCC_ABBA_1 | 192 | 197 | PF00400 | 0.351 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.579 |
LIG_BRCT_MDC1_1 | 330 | 334 | PF00533 | 0.318 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.499 |
LIG_FHA_2 | 219 | 225 | PF00498 | 0.373 |
LIG_FHA_2 | 277 | 283 | PF00498 | 0.339 |
LIG_LIR_Apic_2 | 125 | 129 | PF02991 | 0.527 |
LIG_LIR_Apic_2 | 139 | 143 | PF02991 | 0.494 |
LIG_LIR_Apic_2 | 21 | 26 | PF02991 | 0.318 |
LIG_LIR_Gen_1 | 184 | 194 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 265 | 274 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 289 | 297 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 325 | 334 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 184 | 189 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 191 | 196 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 247 | 251 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 265 | 270 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 289 | 293 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 325 | 329 | PF02991 | 0.352 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.525 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.499 |
LIG_SH2_CRK | 186 | 190 | PF00017 | 0.321 |
LIG_SH2_CRK | 251 | 255 | PF00017 | 0.548 |
LIG_SH2_CRK | 267 | 271 | PF00017 | 0.236 |
LIG_SH2_NCK_1 | 140 | 144 | PF00017 | 0.504 |
LIG_SH2_NCK_1 | 251 | 255 | PF00017 | 0.450 |
LIG_SH2_STAP1 | 124 | 128 | PF00017 | 0.715 |
LIG_SH2_STAP1 | 186 | 190 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.660 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.700 |
LIG_SH3_3 | 152 | 158 | PF00018 | 0.755 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.720 |
LIG_SH3_3 | 167 | 173 | PF00018 | 0.568 |
LIG_SH3_4 | 253 | 260 | PF00018 | 0.583 |
LIG_SUMO_SIM_anti_2 | 25 | 31 | PF11976 | 0.385 |
LIG_SUMO_SIM_par_1 | 318 | 325 | PF11976 | 0.404 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.734 |
MOD_CK2_1 | 238 | 244 | PF00069 | 0.379 |
MOD_CK2_1 | 319 | 325 | PF00069 | 0.425 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.742 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.766 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.743 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.375 |
MOD_GlcNHglycan | 235 | 239 | PF01048 | 0.338 |
MOD_GlcNHglycan | 330 | 333 | PF01048 | 0.579 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.576 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.631 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.360 |
MOD_GSK3_1 | 262 | 269 | PF00069 | 0.505 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.430 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.564 |
MOD_N-GLC_1 | 198 | 203 | PF02516 | 0.313 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.503 |
MOD_N-GLC_2 | 3 | 5 | PF02516 | 0.391 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.710 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.571 |
MOD_NEK2_2 | 319 | 324 | PF00069 | 0.366 |
MOD_PIKK_1 | 260 | 266 | PF00454 | 0.465 |
MOD_PKA_2 | 54 | 60 | PF00069 | 0.503 |
MOD_Plk_1 | 207 | 213 | PF00069 | 0.326 |
MOD_Plk_1 | 288 | 294 | PF00069 | 0.406 |
MOD_Plk_1 | 60 | 66 | PF00069 | 0.521 |
MOD_Plk_2-3 | 8 | 14 | PF00069 | 0.412 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.343 |
MOD_Plk_4 | 244 | 250 | PF00069 | 0.351 |
MOD_Plk_4 | 266 | 272 | PF00069 | 0.348 |
MOD_ProDKin_1 | 103 | 109 | PF00069 | 0.773 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.447 |
TRG_DiLeu_BaEn_1 | 289 | 294 | PF01217 | 0.457 |
TRG_ENDOCYTIC_2 | 186 | 189 | PF00928 | 0.426 |
TRG_ENDOCYTIC_2 | 267 | 270 | PF00928 | 0.428 |
TRG_ER_diArg_1 | 164 | 167 | PF00400 | 0.485 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P229 | Leptomonas seymouri | 54% | 100% |
A0A0N1ILD7 | Leptomonas seymouri | 24% | 74% |
A0A0S4JBP2 | Bodo saltans | 26% | 74% |
A0A1X0NCU6 | Trypanosomatidae | 49% | 100% |
A0A1X0NKY5 | Trypanosomatidae | 33% | 76% |
A0A1X0NTS2 | Trypanosomatidae | 26% | 75% |
A0A3Q8IMS6 | Leishmania donovani | 68% | 100% |
A0A3R7KFH5 | Trypanosoma rangeli | 45% | 73% |
A0A3S7WWY0 | Leishmania donovani | 24% | 100% |
A4HDK3 | Leishmania braziliensis | 61% | 85% |
A4HDK4 | Leishmania braziliensis | 61% | 85% |
A4HZP7 | Leishmania infantum | 24% | 100% |
A4I0X7 | Leishmania infantum | 68% | 100% |
A4I0X8 | Leishmania infantum | 99% | 100% |
C9ZWH1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AVK3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AWY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 100% |
E9AWY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4QAJ2 | Leishmania major | 95% | 100% |
Q4QAJ3 | Leishmania major | 68% | 100% |
Q4QBX6 | Leishmania major | 27% | 100% |
V5B9E6 | Trypanosoma cruzi | 32% | 87% |
V5BK04 | Trypanosoma cruzi | 49% | 100% |